| Kilitch Drugs (India) Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524500 |
NSE Symbol : KILITCH |
P/E(TTM) : 18.46 |
|
ISIN Demat : INE729D01010 |
Div & Yield% : 0.00 |
EPS(TTM) : 18.17 |
|
Book Value(₹) : 180.73 |
Market Cap(₹Cr) : 586.31 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 37.81 | 34.12 | 56.30 | 46.51 | 45.35 | 33.42 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 37.81 | 34.12 | 56.30 | 46.51 | 45.35 | 33.42 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 7.61 | 3.50 | 2.32 | 2.37 | 5.81 | 3.21 |
| Total Income | 45.42 | 37.62 | 58.63 | 48.88 | 51.16 | 36.63 |
| Total Expenditure | 34.14 | 30.55 | 42.40 | 38.40 | 39.75 | 30.20 |
| PBIDT | 11.28 | 7.07 | 16.23 | 10.49 | 11.40 | 6.43 |
| Interest | 0.68 | 0.59 | 0.72 | 0.49 | 0.42 | 0.49 |
| PBDT | 10.60 | 6.48 | 15.51 | 9.99 | 10.98 | 5.94 |
| Depreciation | 0.53 | 0.50 | 0.51 | 0.47 | 0.40 | 0.35 |
| Tax | 1.78 | 1.30 | 3.56 | 2.87 | 2.16 | 1.27 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.42 | -0.11 | 0.07 | -0.23 | -0.43 | 0.27 |
| Reported Profit After Tax | 8.72 | 4.79 | 11.37 | 6.88 | 8.85 | 4.05 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 8.72 | 4.79 | 11.37 | 6.88 | 8.85 | 4.05 |
| EPS (Unit Curr.) | 5.27 | 2.98 | 7.07 | 4.28 | 5.50 | 2.52 |
| EPS (Adj) (Unit Curr.) | 5.27 | 2.92 | 6.92 | 4.19 | 5.38 | 2.47 |
| Calculated EPS (Unit Curr.) | 4.99 | 2.98 | 7.07 | 4.28 | 5.50 | 2.52 |
| Calculated EPS (Adj) (Unit Curr.) | 4.99 | 2.92 | 6.92 | 4.19 | 5.38 | 2.47 |
| Calculated EPS (Ann.) (Unit Curr.) | 19.94 | 11.92 | 28.29 | 17.12 | 22.00 | 10.08 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 19.94 | 11.66 | 27.69 | 16.75 | 21.53 | 9.86 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 17.48 | 16.08 | 16.08 | 16.08 | 16.08 | 16.08 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 29.83 | 20.72 | 28.83 | 22.55 | 25.14 | 19.24 |
| PBDTM(%) | 28.03 | 18.99 | 27.55 | 21.48 | 24.21 | 17.77 |
| PATM(%) | 23.06 | 14.04 | 20.20 | 14.79 | 19.51 | 12.12 |